355 related articles for article (PubMed ID: 1830098)
1. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
[TBL] [Abstract][Full Text] [Related]
3. Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice.
Aguilar MA; Marí-Sanmillán MI; Morant-Deusa JJ; Miñarro J
Behav Neurosci; 2000 Apr; 114(2):389-400. PubMed ID: 10832799
[TBL] [Abstract][Full Text] [Related]
4. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
7. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Swerdlow NR; Keith VA; Braff DL; Geyer MA
J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
Costanza RM; Barber DJ; Terry P
Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
Jacobson SM; Prus AJ
Behav Pharmacol; 2010 Oct; 21(7):654-9. PubMed ID: 20729715
[TBL] [Abstract][Full Text] [Related]
10. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
11. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
Coffin VL; Latranyi MB; Chipkin RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351
[TBL] [Abstract][Full Text] [Related]
12. Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.
Levin ED
Behav Neural Biol; 1988 Sep; 50(2):240-5. PubMed ID: 2906537
[TBL] [Abstract][Full Text] [Related]
13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
14. Modification of avoidance responding by amphetamine and dopamine receptor antagonists.
Jakubowska-Doğru E
Pol J Pharmacol; 1999; 51(4):301-9. PubMed ID: 10540961
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
16. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
[TBL] [Abstract][Full Text] [Related]
18. Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat.
O'Tuathaigh CM; Moran PM
Psychopharmacology (Berl); 2002 Jul; 162(3):225-31. PubMed ID: 12122479
[TBL] [Abstract][Full Text] [Related]
19. [The influence of systemically administered selective dopamine antagonists of D1 and D2/D3 types on alimentary and escape conditioned placing reactions in cats].
Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(4):489-94. PubMed ID: 15481386
[TBL] [Abstract][Full Text] [Related]
20. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
